Filing metadata

Accession number
0001104659-24-102146
Form type
Form 4
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
Sep 23, 2024
Reporting period
Sep 19, 2024
Description
Insider transaction

Explore SEC Filings Hub